|
Harvard School of Public Health Cancer Research |

Biomedical
research in the latter half of the twentieth century has been characterized
by the widespread use of quantitative methods. This has been especially
true in cancer research where new statistical methodologies have been
developed to meet special problems encountered in clinical trials, epidemiological
and laboratory studies. In general the methods of biostatistics/statistics
have proved to be fundamental in analysis of high dimensional data sets.
Recent discoveries of the relation of genetic mutations to disease have
reinforced the need to develop and apply methods of biostatistics
to the large data explosion about to be triggered by advances in chip
technology. The Department is one of the major centers for carrying out
clinical trials.
|